Stocks and Investing Stocks and Investing
Fri, June 28, 2024
Thu, June 27, 2024

Keith Tapper Initiated (TSHA) at Buy and Held Target at $5 on, Jun 27th, 2024


Published on 2024-10-28 12:09:14 - WOPRAI, Keith Tapper
  Print publication without navigation


Keith Tapper of BMO Capital, Initiated "Taysha Gene Therapies, Inc." (TSHA) at Buy and Held Target at $5 on, Jun 27th, 2024.

Keith has made no other calls on TSHA in the last 4 months.



There are 7 other peers that have a rating on TSHA. Out of the 7 peers that are also analyzing TSHA, 0 agree with Keith's Rating of Hold.



These are the ratings of the 7 analyists that currently disagree with Keith


  • Kristen Kluska of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $7 on, Thursday, June 20th, 2024
  • Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $5 on, Thursday, June 20th, 2024
  • Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $7 on, Wednesday, June 19th, 2024
  • Geulah Livshits of "Chardan Capital" Maintained at Strong Buy and Held Target at $7 on, Tuesday, June 18th, 2024
  • Eun Yang of "Jefferies" Initiated at Strong Buy with Increased Target to $8 on, Tuesday, May 14th, 2024
  • Christopher Raymond of "Piper Sandler" Initiated at Buy and Held Target at $9 on, Tuesday, April 9th, 2024
  • Whitney Ijem of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $7 on, Thursday, March 21st, 2024
Contributing Sources